BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 311683)

  • 21. Effect of high-dose methotrexate with citrovorum factor on human granulopoiesis.
    Schremi W; Lohrmann HP
    Cancer Res; 1979 Oct; 39(10):4195-9. PubMed ID: 314330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-dose methotrexate with folinic acid rescue.
    Bender JF; Grove WR; Fortner CL
    Am J Hosp Pharm; 1977 Sep; 34(9):961-5. PubMed ID: 333910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prevention of methotrexate toxicity by thymidine infusions in humans.
    Ensminger WD; Frei E
    Cancer Res; 1977 Jun; 37(6):1857-63. PubMed ID: 870189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [High-dose methotrexate with citrovorum factor rescue in osteogenic carcinoma].
    Levi M; Sulkes A; Katz E; Rizel S; Biran S
    Harefuah; 1980 Sep; 99(5-6):110-3. PubMed ID: 6970707
    [No Abstract]   [Full Text] [Related]  

  • 25. Incidence of drug-related deaths secondary to high-dose methotrexate and citrovorum factor administration.
    Von Hoff DD; Penta JS; Helman LJ; Slavik M
    Cancer Treat Rep; 1977 Jul; 61(4):745-8. PubMed ID: 301783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced citrovorum factor rescue for high-dose methotrexate therapy in childhood malignancies.
    Sasaki K; Tanaka J; Murakami T; Matuoka H; Fujimoto T; Taguchi H
    Cancer Drug Deliv; 1985; 2(1):77-86. PubMed ID: 3876873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Determination of MTX plasma concentration in cancer patients following administration of HD-MTX-CFR (author's transl)].
    Wang YX; Zhang QF; Zhang NF; Zhang XL; Kang SH
    Yao Xue Xue Bao; 1981 Nov; 16(11):815-20. PubMed ID: 6979162
    [No Abstract]   [Full Text] [Related]  

  • 28. Improved therapeutic index of methotrexate with "leucovorin rescue".
    Levitt M; Mosher MB; DeConti RC; Farber LR; Skeel RT; Marsh JC; Mitchell MS; Papac RJ; Thomas ED; Bertino JR
    Cancer Res; 1973 Jul; 33(7):1729-34. PubMed ID: 4541737
    [No Abstract]   [Full Text] [Related]  

  • 29. Phase I study of high-dose methotrexate with thymidine and low-dose leucovorin.
    Bruno S; Grindey G; Zakrzewski S; Priore R; Kinahan J; Moayeri H; Ledesma E; Mittelman A; Creaven P
    Cancer Res; 1982 Nov; 42(11):4824-6. PubMed ID: 6982097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Studies on high-dose methotrexate with citrovorum factor rescue therapy in children: analysis of bone marrow cell kinetics by flow cytometry].
    Tsurusawa M; Sasaki K; Matsuoka H; Katano N; Fujimoto T
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1827-32. PubMed ID: 3876075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methotrexate with thymidine, inosine, and allopurinol rescue: a phase I clinical study.
    Dady PJ; Taylor GA; Muindi JF; Calvert AH; Smith IE; Smyth JF; Harrap KR
    Cancer Treat Rep; 1981; 65 Suppl 1():37-43. PubMed ID: 7326664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative effects of citrovorum factor and carboxypeptidase G1 on cerebrospinal fluid-methotrexate pharmacokinetics.
    Abelson HT; Ensminger W; Rosowsky A; Uren J
    Cancer Treat Rep; 1978 Oct; 62(10):1549-52. PubMed ID: 309355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase II study of high-dose methotrexate in the treatment of patients with non-small cell carcinoma of the lung: an Eastern Cooperative Oncology Group study.
    Ettinger DS; Stanley KE; Nystrom JS
    Cancer Treat Rep; 1980; 64(10-11):1017-21. PubMed ID: 6970075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-dose methotrexate for the patient with osteogenic sarcoma.
    Nirenberg A
    Am J Nurs; 1976 Nov; 76(11):1776-80. PubMed ID: 136192
    [No Abstract]   [Full Text] [Related]  

  • 35. [High dose methotrexate with CF rescue therapy in patients with head and neck cancer].
    Inuyama Y; Taketa C; Hiroto I; Fujii M; Takaoka T; Tanaka J; Matsuura S; Satake B; Takeoda S; Nishijima W
    Gan To Kagaku Ryoho; 1984 Sep; 11(9):1823-31. PubMed ID: 6332576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [High dose of methotrexate-leucovorin treatment in advanced non-Hodgkin's lymphoma].
    Kawarabayashi K; Yoshikawa T; Sannomiya Y; Hashimoto K; Araki J; Park K; Tatumi Y; Kamitani T; Im T; Tatumi N
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2493-9. PubMed ID: 6606395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of a massive dosage of methotrexate and leucovorin rescue therapy on acute leukemia and malignant lymphoma].
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):421-32. PubMed ID: 6764106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose methotrexate therapy of childhood acute lymphoblastic leukemia: lack of relation between serum methotrexate concentration and creatinine clearance.
    Joannon P; Oviedo I; Campbell M; Tordecilla J
    Pediatr Blood Cancer; 2004 Jul; 43(1):17-22. PubMed ID: 15170885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New approaches to cancer chemotherapy with methotrexate.
    Frei E; Jaffe N; Tattersall MH; Pitman S; Parker L
    N Engl J Med; 1975 Apr; 292(16):846-51. PubMed ID: 1078714
    [No Abstract]   [Full Text] [Related]  

  • 40. [High-dose methotrexate with citrovorum factor rescue in the treatment of malignant tumors (author's transl)].
    Wang QL; Sun Y; Zhou JC; Song SZ; Lu L; Ye ZS
    Zhonghua Zhong Liu Za Zhi; 1979; 1(2):144-9. PubMed ID: 317948
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.